Valid for Submission
D72.822 is a billable code used to specify a medical diagnosis of plasmacytosis. The code is valid for the fiscal year 2021 for the submission of HIPAA-covered transactions. The ICD-10-CM code D72.822 might also be used to specify conditions or terms like non-malignant lymphocyte and/or plasma cell disorder or plasmacytosis.
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code D72.822 are found in the index:
- - Plasmacytosis - D72.822
Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Non-malignant lymphocyte AND/OR plasma cell disorder
- Plasmacytosis
Diagnostic Related Groups
The ICD-10 code D72.822 is grouped in the following groups for version MS-DRG V38.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2020 through 09/30/2021.
- 814 - RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MCC
- 815 - RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH CC
- 816 - RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITHOUT CC/MCC
Convert D72.822 to ICD-9
- 288.64 - Plasmacytosis
Code Classification
Code History
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
(First year ICD-10-CM implemented into the HIPAA code set) - FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021